ClinicalTrials.gg
Sign In

Drug

Extended Release Flucytosine clinical trials

A product of Flucytosine; its studies count on that page too.

studies test it
9
open now
1
in phase 3
2
first study started
2011

Keep track of what changes. Save the Extended Release Flucytosine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

Toca FC
7
5-Fluorocytosine
5
5-FC
4
Flucytosine
4
flucytosine, 5-FC, 5-FC XR, Toca FC
2

Studies by the year they started

9 studies that test it; most in 2011 (1)

Studies that test Extended Release Flucytosine, by start year
YearStudies
20111
20121
20141
20151
20161
20171
20191
20201
20251

By phase

A phase 1/2 study counts in both.

Phase 1
7
Phase 2
3
Phase 3
2

What it is tested for

Each study’s main condition, where its own words name it.

Glioblastoma
5
Glioma
2
Lymphoma
1
Non-Muscle Invasive Bladder Neoplasms
1

Who runs them

Industry 7 · Other 2

Tocagen Inc. (7) · University of California, San Francisco (1) · NRG Oncology (1)

Often tested with

Tested in the same studies.

Vocimagene amiretrorepvec (7) · Temozolomide (1)

Studies

Open first, then newest update. How each study uses Extended Release Flucytosine is read from its arms, and is right about nine times in ten.

Testing it · 9

Given in every arm · 1 — Extended Release Flucytosine is usual care beside what is tested